NCRIS
Health Group
Working together to keep Australians healthy through research innovation.
Health and medical researchers investigate solutions to complex problems that are often not easily solved by a single discipline. The NCRIS Health Group is aimed at enabling them collaboratively throughout the innovation and translational process.
Enabling Health Innovation and Translation
Health Group infrastructure
The Health Group offers seamless access to world class research infrastructure and expertise.
Governance
The NCRIS Health Group is a cross-capability collaboration established via a Collaboration Agreement. The Group is coordinated via a leadership group comprising the Board Chairs and Chief Executives of the five member capabilities.
NCRIS Health Group Flyer
NCRIS Health Group Highlights
Phenomics Australia and Bioplatforms Australia support a National Initiative to develop the Australian Psychiatric Research Knowledge Bank
Phenomics Australia and Bioplatforms Australia are proud to announce a new national initiative aimed at advancing knowledge of the causality and treatment of mental disorders through
Pipeline Accelerator 2024-25 Round 2 Now Open
Applications for Pipeline Accelerator 2024-25 Round 2 vouchers are now open In this Pipeline Accelerator round, Phenomics Australia is partnering with Therapeutic innovation Australia (TIA), ANSTO’s
Group of Senior Officials (GSO) on Global Research Infrastructures visit NCRIS facilities
In coordination with the International Conference on Research Infrastructures 2024 (ICRI 2024), the 16th Meeting of the GSO was held at The University of Queensland Brisbane
ICRI2024: Health research infrastructure ecosystems: Stronger together
Hosted by the NCRIS Health Group in alignment with the International Conference on Research Infrastructures (ICRI 2024), the symposium united health research infrastructure experts from Europe,
Pipeline Accelerator 2024-25 (Round 1) successful recipients announced
Phenomics Australia in partnership with Therapeutic Innovation Australia (TIA), and the National Deuteration Facility (NDF), is thrilled to announce the successful recipients of the Pipeline Accelerator
EMBL Australia joins NCRIS Health Group to enhance collaborative health research
EMBL Australia has signed a Memorandum of Understanding (MOU) to join the NCRIS Health Group, strengthening Australian collaborative health research. The NCRIS Health Group, supported by
Voucher scheme to support translational research is now open for applications
Pipeline Accelerator 2024-25 Round 1 To encourage access to research infrastructure, Therapeutic Innovation Australia (TIA) developed the Pipeline Accelerator, a voucher-style scheme that subsidises the cost of access
The NCRIS Health Group warmly welcomes the release of Australia’s RNA Blueprint
The NCRIS Health Group warmly welcomes the release of Australia’s RNA Blueprint by the Australian Department of Industry, Science and Resources. The NCRIS Health Group includes
Phenomics Australia and Therapeutic Innovation Australia partnership reinforces commitment to address the medical products challenge
In partnership with Therapeutic Innovation Australia (TIA), Phenomics Australia is pleased to announce the successful recipients of the Pipeline Accelerator 2023-24 (Round 2). Through the National